Related Experiment Video
Updated: Sep 20, 2025

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
Understanding the circulating forms of cardiac troponin: insights for clinical practice
Panpan Lv1,2, Peng Zhang3, Yuxiang Dai1,4,5
1Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases, Fudan University, Shanghai, P.R. China.
Insights
Cardiac troponin (cTn) levels can rise due to myocardial infarction (MI) or other conditions. Understanding the different forms of cTn in the blood is crucial for accurate diagnosis and treatment.
Area of Science:
- Biochemistry
- Cardiology
- Clinical Diagnostics
Background:
- Ischemic heart disease, particularly acute coronary syndrome (ACS), is a leading global cause of death and emergency hospital admissions.
- Cardiac troponin I (cTnI) and cardiac troponin T (cTnT) are established biomarkers for diagnosing myocardial infarction (MI).
- High-sensitivity cardiac troponin (hs-cTn) assays improve detection of low troponin concentrations but can be elevated in non-MI conditions.
Purpose of the Study:
- To review research on circulating forms of cardiac troponin (cTn).
- To explore mechanisms of cTn elevation in various pathophysiological states.
- To discuss the clinical significance of cTn in conditions beyond MI, such as endurance exercise and chronic kidney disease.
Main Methods:
- Literature review of studies on cardiac troponin isoforms and their detection.
- Analysis of pathophysiological mechanisms leading to elevated cTn.
- Examination of clinical data associating cTn levels with different medical conditions.
Main Results:
- Cardiac troponin exists in heterogeneous forms in the bloodstream.
- Elevated cTn levels can occur in conditions other than MI, posing diagnostic challenges.
- Understanding cTn heterogeneity is clinically significant for accurate interpretation.
Conclusions:
- Accurate characterization of circulating cTn forms is essential for reliable diagnosis.
- Further research into cTn heterogeneity can improve diagnostic strategies.
- Developing improved immunodetection methods for cTn is important.
Abstract:
Ischemic heart disease remains the leading cause of death globally, with acute coronary syndrome (ACS) being the main reason for emergency hospital admissions and thus representing a significant health care issue worldwide. Cardiac troponin I (cTnI) and cardiac troponin T (cTnT) are widely recognized biomarkers of cardiomyocyte injury and the gold-standard biomarkers for diagnosing myocardial infarction (MI). High-sensitivity cardiac troponin (hs-cTn) assays have the ability to accurately detect low cTn concentrations and document minor increases. However, in addition to MI, various other pathophysiological states can trigger elevated cardiac troponin levels, thus creating potential challenges in the diagnostic process. As cTn released into the bloodstream exists in heterogeneous forms, improving our understanding and accurately characterizing these forms across various etiologies might hold clinical significance. In this review, we add to the field by offering an overview of research on possible circulating forms of cTn, the mechanisms of cTn elevation, and the clinical significance of cTn following conditions such as MI, endurance exercise, and chronic kidney disease, thus highlighting the importance and challenge of understanding of the circulating forms of cTn and possible strategies for cTn immunodetection.
More Related Videos
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations